| Vorliegende Sprache |
eng |
| Hinweise auf parallele Ausgaben |
260809705 Buchausg. u.d.T.: ‡Baecker, Philipp N.: Real options and intellectual property |
| ISBN |
978-3-540-48263-5 |
| Name |
Baecker, Philipp N. |
| T I T E L |
Real Options and Intellectual Property |
| Zusatz zum Titel |
Capital Budgeting Under Imperfect Patent Protection |
| Verlagsort |
Berlin, Heidelberg |
| Verlag |
Springer-Verlag Berlin Heidelberg |
| Erscheinungsjahr |
2007 |
| 2007 |
| Umfang |
Online-Ressource (X, 278 p. 47 illus, digital) |
| Reihe |
SpringerLink. Bücher |
| Notiz / Fußnoten |
Includes bibliographical references and index |
| Weiterer Inhalt |
Introduction; Patent Protection, the Firm, and the Economy; Uncertainty, Irreversibility, and Flexibility; Patent Protection in the Pharmaceutical Industry; Introduction and Related Work; Patents as Investment Opportunities; Patent Risk as Jumps in the Underlying Process; From Business Shifts to Jump Processes; Preliminary Conclusion; Introduction and Related Work; Patent Risk as an Option to Litigate; Preliminary Conclusion; Conclusion |
| Titelhinweis |
Buchausg. u.d.T.: ‡Baecker, Philipp N.: Real options and intellectual property |
| ISBN |
ISBN 978-3-540-48264-2 |
| Klassifikation |
KCBM |
| KCLF |
| BUS027000 |
| *91B28 |
| 91-02 |
| 332 |
| 338.476151 |
| 330 |
| HG1-9999 |
| QR 525 |
| SI 853 |
| Kurzbeschreibung |
This book proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. The text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management. |
| 2. Kurzbeschreibung |
Over the last years, due to intensive competition in the knowledge economy, legal aspects surrounding intellectual property (IP) rights - including litigation and settlement - have continuously gained in importance. Correspondingly, professional IP management has become an indispensable element of successful value-based management (VBM) in research-intensive firms. With this text, the author proposes an integrated approach to patent risk and capital budgeting in pharmaceutical research and development (R and D), developing an option-based view (OBV) of imperfect patent protection, which draws upon contingent-claims analysis, stochastic game theory, as well as novel numerical methods. Bridging a widening gap between recent advances in the theory of financial analysis and current challenges faced by pharmaceutical companies, the text re-initiates a discussion about the contribution of quantitative frameworks to value-based R and D management. |
| 1. Schlagwortkette |
Pharmazeutische Industrie |
| Forschung und Entwicklung |
| Investitionsplanung |
| Realoption |
| Patentschutz |
| Risiko |
| Forschung und Entwicklung |
| Investitionsplanung |
| Realoption |
| Patentschutz |
| Risiko |
| ANZEIGE DER KETTE |
Pharmazeutische Industrie -- Forschung und Entwicklung -- Investitionsplanung -- Realoption -- Patentschutz -- Risiko -- Forschung und Entwicklung -- Investitionsplanung -- Realoption -- Patentschutz -- Risiko |
| SWB-Titel-Idn |
276335104 |
| Signatur |
Springer E-Book |
| Bemerkungen |
Elektronischer Volltext - Campuslizenz |
| Elektronische Adresse |
$uhttp://dx.doi.org/10.1007/978-3-540-48264-2 |
| Internetseite / Link |
Volltext |
| Siehe auch |
Inhaltstext |
| Siehe auch |
Volltext |
| Siehe auch |
Inhaltsverzeichnis |
| Siehe auch |
Cover |
| Siehe auch |
Inhaltstext |
